Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine Augmentation for Anxiety/Mood Disorders
NCT00912535Phase 4Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- May 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in anxiety disorder, mood disorder, sponsored by Chang Gung Memorial Hospital. Started May 2009; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
anxiety disordermood disorder
Beyond the preview
Go deeper on NCT00912535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912535.